IMCC (IM Cannabis) Quality Rank


IMCC IM Cannabis Corp IMCC
36 GF Score
Price $0.16
GF Value $1.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is IM Cannabis Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

IM Cannabis Quality Rank Related Terms

IMCC
36GF Score
IM Cannabis Corp IMCC
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.16 is trading 88.8% below its estimated GF Value™ of $1.39. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Quality Rank:
  • GF Value™: $1.39 vs. price of $0.16 (88.8% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score

Get the complete analysis for IMCC

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$1.39
GF Value